Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Treasury Shares (2020 - 2023)

Terns Pharmaceuticals' Treasury Shares history spans 4 years, with the latest figure at $364594.0 for Q3 2023.

  • For Q3 2023, Treasury Shares rose 261.41% year-over-year to $364594.0; the TTM value through Sep 2023 reached $364594.0, up 261.41%, while the annual FY2022 figure was $128280.0, N/A changed from the prior year.
  • Treasury Shares reached $364594.0 in Q3 2023 per TERN's latest filing, down from $372301.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $388103.0 in Q1 2023 to a low of $71429.0 in Q1 2021.
  • Average Treasury Shares over 4 years is $186786.8, with a median of $100880.0 recorded in 2022.
  • Peak YoY movement for Treasury Shares: increased 4.76% in 2022, then soared 418.65% in 2023.
  • A 4-year view of Treasury Shares shows it stood at $83334.0 in 2020, then dropped by 14.29% to $71429.0 in 2021, then surged by 79.59% to $128280.0 in 2022, then skyrocketed by 184.22% to $364594.0 in 2023.
  • Per Business Quant, the three most recent readings for TERN's Treasury Shares are $364594.0 (Q3 2023), $372301.0 (Q2 2023), and $388103.0 (Q1 2023).